Mestastop® Solutions

Mestastop’s Major Achievements in Metastasis Research for the Year 2024 Mestastop envisions a future where metastasis becomes more manageable, empowering better outcomes and lasting hope by focusing on ✅ early detection ✅ innovative models ✅ global collaboration Join us in "giving life a second chance" #earlydetection #cancerresearch #cancerdiagnostics #metastasis #cancermodels #drugrepurposing

Here's how we are envisioning to transform the future of Global Cancer Care: 👇 ⬇ Innovate Metastasis Research: Develop advanced models to understand cancer spread and create precise diagnostic tools for early detection. ⬇ Targeted Therapies: Design treatments that address the root causes of metastasis, reducing the risk of cancer spread. ⬇ Global Collaboration: Partner with research institutions and healthcare providers to accelerate treatment development. ⬇ Patient-Centric Care: Focus on accessible, personalized, and effective therapies to improve patient outcomes. ⬇ Education & Awareness: Raise awareness and educate the medical community to promote early detection and proactive care. Mestastop® Solutions aims to transform cancer care, making metastasis more manageable and treatable worldwide. Let's talk to explore synergies. Contact us ⬇ +91 9177884450

Step into our lab and see how we’re pushing the boundaries of cancer research. From testing cancer cell invasion with intravasation assays to analyzing primary cultures from patient samples, we’re dedicated to understanding and halting metastasis. Our work brings us closer to breakthroughs that can lead to more effective, targeted #cancer therapies.

“It takes two flints to make a fire.” – Louisa May Alcott Let's fire up together and advance the research on #metastasis! We are open to collaborations. Reach us at bd@mestastop.com We are highly thankful to all our collaborators: Bangalore Bioinnovation Centre Syngene International Limited Vipragen Biosciences Pvt Ltd OncoBone Therapeutics Ltd Ectica Technologies Institute of Bioinformatics and Applied Biotechnology (IBAB) ImmunoBiome Inc. Peptris Technologies ACUBIOSYS PVT LTD St. John's Research Institute GITAM Deemed University Rajiv Gandhi Cancer Institute and Research Centre GRK Research Laboratories

Light, camera, ACTION! It's time for our October Spotlight! Saif wahid and Nikhil Babu Your remarkable performance raises the bar for the entire team. Thank you for consistently achieving outstanding results! #teamwork #companyculture #employeesuccess

Mestastop’s Approach to Understanding Metastasis - Innovation in Models #cancer #metastasis #metastasisbiology

"Coming together is a beginning. Keeping together is progress. Working together is success." – Henry Ford Meet our passionate Drug Discovery Team! #metastasis #cancer #team #drugdiscovery #usa #europeanunion

The Importance of Patient-Centered Communication in Cancer Care ✅ Quality care varies among stakeholders: All cancer care stakeholders, including patients, have different views on what defines "quality care." Aligning care with patient values is crucial. ✅ Communication enhances care: Clear, effective communication improves the quality of care (QOC) and builds trust between patients and doctors. It empowers patients, especially when they understand their treatment and next steps. ✅ Balanced information sharing is key: Providing the right amount of information is essential—too much can overwhelm patients, while too little can increase anxiety. ✅ Shared decision-making (SDM): Involving patients in treatment decisions improves satisfaction and trust, though it may not always boost self-efficacy (confidence in managing their health). ✅ Emotional support matters: Addressing emotional needs and uncertainties enhances the patient experience and strengthens bonds with #healthcare providers. ✅ Technology’s limited role: Access to electronic medical records (EMRs) helps engagement but doesn’t significantly impact outcomes. ✅ Mestastop: Innovating Metastasis Care Focusing on metastasis: Mestastop’s research targets #cancercell spread, developing tools and therapies to stop metastasis, a major challenge in #cancertreatment. ✅ Integrating PCC: Mestastop’s approach aligns with patient-centered care by tailoring treatments to individual needs, ensuring both #scientific #innovation and #patient well-being. ✅ Conclusion Patient-centered communication is essential for improving #cancercare quality, trust, and treatment satisfaction. Mestastop’s focus on stopping #metastasis with patient-centered approaches aims to improve both #survival outcomes and #care experiences.

Is there any proven way to stop a cancer cell from being metastatic? We all know metastasis is the final stage of cancer. In this stage, cancer cells form new #tumors in other organs. Traditionally, it was believed that cancer cells become metastatic through #genetic changes that give them new abilities like moving, invading other tissues, and surviving in new environments. Our approach at Mestastop to look into cancer metastasis is different with a unique strategy. We believe "Plasticity shifts" allow cancer cells to switch between different cell states, which can help them invade, spread, and evade treatment. Plasticity shift is a #hallmark of cancer. It is the ability of cancer cells to change their #phenotype in response to their environment. This ability is driven by epigenetic and transcriptional reprogramming. Plasticity shifts are dynamic and reversible, and they can be controlled by specific pathways.  This makes them a promising target for #cancertherapy, as it may be possible to prevent cells from entering highly aggressive or resistant states. We have proved through multiple case studies that #plasticityshift is the underlying cause of #metastasis.

Inside Mestastop's lab🔬 Priyanka and Nikhil chat......."angiogenic switch" 😮 ....."dormant & aggressive tumors"......"early detection" 🤔 All captured in the wild 😅 ! Our metastasis specialists are too curious to be handled 🤣 #cancer #metastasis #illustration #sciencecommunication